SCHEMBL28035847

SCHEMBL28035847

CCCCn1nc(C(N)=O)cc1-c1ccc(F)cc1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 6/20 0.67
HDAC6 Q9UBN7 7/20 0.51
HDAC3 O15379 6/20 0.51
HDAC4 P56524 6/20 0.51
HDAC1 Q13547 6/20 0.51
HDAC7 Q8WUI4 6/20 0.51
HDAC2 Q92769 6/20 0.51
HDAC10 Q969S8 6/20 0.51
HDAC11 Q96DB2 6/20 0.51
HDAC8 Q9BY41 6/20 0.51
HDAC9 Q9UKV0 6/20 0.51
HDAC5 Q9UQL6 6/20 0.51
CNR1 P21554 3/20 0.46
CNR2 P34972 1/20 0.46
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28035907 0.77 HDAC6 (0.50) SMPD1HDAC6HDAC3HDAC4HDAC1
SCHEMBL1234211 0.75 KDM4E (0.46) SMPD1CNR1CNR2KDM4E
SCHEMBL1738072 0.74 MARS1 (0.63) SMPD1HDAC6HDAC3HDAC4HDAC1
SCHEMBL1233594 0.74 CNR1 (0.44) SMPD1CNR1CNR2
SCHEMBL4019481 0.73 KDM4E (0.48) SMPD1KDM4EALDH1A1HPGD
SCHEMBL27748917 0.73 CNR1 (0.59) CNR1CNR2
SCHEMBL28244390 0.72 SMPD1 (0.51) SMPD1CNR1CNR2
SCHEMBL29988830 0.71 SMPD1 (0.58) SMPD1HDAC6HDAC3HDAC4HDAC1
SCHEMBL14678038 0.71 MARS1 (0.50) SMPD1KDM4EALDH1A1HPGD
SCHEMBL1233430 0.70 CNR1 (0.42) SMPD1CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104945324-A Sulfur-based compound with anti-tumor activity and application thereof UNIV SHENYANG PHARMACEUTICAL 2015-09-30 CN claimed
CN-104945324-A Sulfur-based compound with anti-tumor activity and application thereof UNIV SHENYANG PHARMACEUTICAL 2015-09-30 CN disclosed